Psychology Flashcards
Rx:
Social anxiety DO (SAD)
*Self-med with alcohol prior to social event
SSRI
CBT
B-blocker or Benzo = performance-only subtype SAD
*Benzo: 2nd line (avoid in self-med with alc)
Meds that incr methadone (mu-R agonist) effect?
ABx: \+ -nazole (antifungal - cryptococcal meningitis) \+ ciprofloxacin, clarithromycin \+ cimetidine \+ Fluvoxamine
- Pinpoint pupils, sluggish rxn, bradypnea, QTc prolongation (torsade de pointes)
- meta by CYP450, CYP3A4
Diagnosis:
Episodic Psych sx + abd pain + peripheral neuropathy
*onset: midlife
acute intermittent porphyria (AIP)
Diagnosis:
Personality changes, social withdrawal *prior to onset of overt psychosis.
Prodromal schizophrenia
Diagnosis:
1+ unexplained sx, excessive thoughts, anxiety & behaviors in response to sx.
Somatic sx DO
Diagnosis:
Minimal to no sx, preoccupation with idea of having a serious illness
illness anxiety DO
Diagnosis:
Neurologic sx incompatible with anatomy or pathophysiology
Conversion DO (functional neurologic sx DO)
Diagnosis:
Falsification of sx/ inducing inj in the absence of obvious external rewards
Factitious DO
Diagnosis:
Falsification of illness for obvious external rewards
Malingering
Rx:
Anticonvulsant and mood stabilizer for bipolar
- Voltage-gated Na channel blocker
- enhance vail of GABA
Valproate (Valproic acid)
*reduce GABA catabolism
Rx:
Anticonvulsant and mood stabilizer for bipolar
*CYP450 inducer
Carbamazepine
Rx:
Anticonvulsant and mood stabilizer for bipolar
*SE: skin rash, rare Stevens-Johnson syndrome
Lamotrigine
*Stevens Johnson syndrome: life threatening mucocutaneous rxn.
Rx: 2nd Gen antipsychotic
antipsychotic + mood DO
Aripiprazole
RX: SSRI
- Avoided in bipolar DO
- risk of inducing mania
Citalopram
Rx:
Anticonvulsants + epilepsy tx
Levetiracetam
Phenytoin
RX
Mood stabilizer, bipolar DO
*2nd messenger signal transduction (AC»_space; PIP)»_space; decr excitatory neurotransmission.
Lithium
*Toxicity: n/v/d, neuromuscular signs dev later
Rx:
1st line tx of active seizures, acute anxiety, alc withdrawal
*Benzo, enhance affinity of GABA»_space; incr inh potential.
Lorazepam
RX:
generalized anxiety DO (GAD)
- nonbenzo anxiolytic
- no risk of dependence
Buspirone
- partial 5HT_1A R agonist
- no m relaxant, no anticonvulsant (in constrast of GABA-A)
RX:
short acting opioids only for break through pain
hydrocodone, oxycodone
Diagnosis:
+Disinhibition: socially inappropriate behavior
+Apathy
+Hyperorality: change sin diets, sweets, binge eating, consume inedible objects
+Compulsive behavior: simple repetitive speech/motions, complex hoarding/ following new religion
Frontotemporal dementia
*early 50-60s
- tau protein inclusions, TDP-43 protein inclusions
- AD (20-40% of cases)
- initial neuronal loss in frontotemporal lobes
Diagnosis:
- 60-70s
- prominent memory impairment
- Chr 21 (APP gene)
Alzheimer dz
- mild to moderate generalized brain atrophy
- initial neuro loss in parietal and temporal lobs
- tau protein, amyloid plaques
- chr 21, Apolipoprotein E4
Presenilin (component of gamma-secretase complex)
Alzheimer’s disease
involve in cleavage of APP
First line RX for panic DO
SSRI/SNRI
CBT
Acute distress: benzo
Psychotic sx <1mo
Brief psychotic DO
Which personality DO?
Frantic efforts to avoid abandonment
Borderline PD
Tx and Rx:
BMI <18.5 kg/m2
intense fear of weight gain
distorted views of body weight/shape
Anorexia nervosa
Tx: CBT, nutritional rehab
Rx: Olanzapine
Tx and Rx:
BMI <18.5 kg/m2
intense fear of weight gain
distorted views of body weight/shape
Anorexia nervosa
Tx: CBT, nutritional rehab
Rx: Olanzapine (assoc with WG) if tx dont work
Tx and Rx:
Recurrent ep of binge eating
+inappropriate compensatory behavior to prevent WG
+Excess worrying about body shape/weight
Bulimia nervosa
Tx: CBT, nutritional rehab
Rx: SSRI (fluoxetine) + tx
Contraindicate: Bupropion (antidepressant - NE/D reuptake Inh) = risk of seizures
Tx and Rx:
recurrent ep of binge eating
no inappropriate compensatory behaviors
lack of ct during eating
Binge-eating DO
Tx: CBT, behavioral weight loss therapy
Rx: SSRI, Lisdexamfetamine
Withdrawal syndromes from which substance?
tremors, agitation, anxiety, delirium*, psychosis
Alcohol
PE: seizures, tachC, palpitations
Withdrawal syndromes from which substance?
Tremors, anxiety, perceptual* disturbances, psychosis, insomnia.
Benzodiazepines
PE: seizures, tachC, palpitations
Withdrawal syndromes from which substance?
N/v, abd cramping, diarrhea, m aches
opioids
PE: dilated pupils, yawning, piloerection, lacrimation, hyperactive bowel sounds
Withdrawal syndromes from which substance?
incr appetite, hypersomnia, intense psychomotor retardation, severe depression (crash)
stimulants (cocaine, amphetamines)